. Author manuscript; available in PMC: 2010 Oct 27.

Published in final edited form as: J Am Coll Cardiol. 2009 Oct 27;54(18):1706–1712. doi: 10.1016/j.jacc.2009.08.016

Table 1.

Baseline characteristics of subjects found to have moderate sleep apnea, mild (or no) sleep apnea, and severe sleep apnea on baseline study. Patients with moderate sleep apnea did not have subsequent study days with blood sampling.

	Moderate Sleep Apnea (n = 47)	Mild Sleep Apnea (n = 5)	Severe Sleep Apnea (n = 12)
Age (yrs)	59 ± 12	56 ± 12	61 ± 13
Sex (M)	36 (76%)	3 (60%)	11 (92%)
Race (AA)	11(23%)	1 (20%)	4 (33%)
EF (%)	20 ±7	25 ± 6	19 ± 4^*
Cardiomyopathy (Ischemic)	26 (55%)	2 (40%)	6 (50%)
HR (min⁻¹)	68 ± 9	76 ± 12	64 ± 11^*
BMI (kg/m²)	32 ± 7	32 ± 7	34 ± 8
Prescribed medications
Beta Blockade	63(97%)	5 (100%)	12 (100%)
ACE inhibitors or ARB	45(95%)	5 (100%)	12 (100%)
Loop diuretic	41 (87%)	4 (80%)	10 (83%)
BNP (pg/ml) prior to sleep		85 ± 90	243 ± 469

p < 0.05 patients with severe sleep apnea as compared to those with mild sleep apnea on baseline study